SBIR-STTR Award

Validation Of Shuntcheck-Micro-Pumper, A Non-Invasive Diagnostic Procedure For De
Award last edited on: 7/29/13

Sponsored Program
SBIR
Awarding Agency
NIH : NINDS
Total Award Amount
$3,133,286
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Marek Swoboda

Company Information

NeuroDx Development LLC (AKA: Neuro Diagnostic Devices)

3333 Street Road Suite 210
Bensalem, PA 19020
   (215) 645-1280
   neurodxinfo@neurodx.com
   www.neurodx.com
Location: Single
Congr. District: 01
County: Bucks

Phase I

Contract Number: 1R43NS067772-01
Start Date: 3/1/10    Completed: 2/28/11
Phase I year
2010
Phase I Amount
$143,737
This Phase 1 SBIR will develop a portable, non-invasive tool which will improve the diagnostic accuracy of kinetic shunt patency testing, including radionuclide studies or ShuntCheck tests, in pediatric hydrocephalus patients. This will improve clinical care for pediatric hydrocephalus patients with suspect shunt malfunction. Hydrocephalus is a common condition in which CSF accumulates in the brain ventricles, potentially leading to brain damage and death. It is corrected by placing a VP shunt that carries excess CSF away. Although enormously successful, shunts eventually fail, usually by obstruction. However, the clinical symptoms of shunt obstruction, primarily including headache and nausea, are non-specific, making shunt failure challenging to diagnose. Suspected obstruction is typically investigated using static MRI and CT scans which are expensive, and require evidence of fluid accumulation in serial images, precluding prediction of shunt failure. Exposure to radiation is also significant in shunted children, who may require several shunt investigations annually. Radionuclide studies, which provide dynamic measures of shunt CSF flow, are invasive and carry the risk of infection. They also have reduced diagnostic specificity due to intermittent shunt flow - patent shunts do not flow continuously leading to a high level of false positive readings. A new, non-invasive test for shunt flow, ShuntCheck, also suffers from reduced specificity due to intermittent shunt flow. There are currently no tools for differentiating between intermittently flowing patent shunts and occluded shunts. NeuroDx Development (NeuroDx) has recently developed and bench tested a tool which generates a reproducible level of CSF flow through patent shunts. Used in conjunction with radionuclide studies or ShuntCheck testing, this new device can improve diagnostic specificity of both test methods. The NeuroDx "Micro-Pumper" is a small device which is held against the shunt valve during the radionuclide or ShuntCheck test. The device provides specific vibration pulses to the valve, creating a controlled level of CSF flow through the valve. Using a bench model of CSF flow, we have shown that the Micro-Pumper, used in combination with ShuntCheck can differentiate between non-flowing patent shunts and occluded or partially occluded shunts. The goal of this Phase 1 project is to extend these preliminary findings to develop a clinic-ready prototype Micro-Pumper device and to verify its ability to improve ShuntCheck's specificity in our bench model. In Phase 2, we will test the Micro- Pumper/ShuntCheck combination in a series of human studies, beginning with a 30 patient pilot study and concluding with a 300 patient clinical validation study comparing ShuntCheck patency results to clinical outcomes of symptomatic pediatric patients who present at the Emergency Departments of Children's Hospitals. By the end of Phase 2, we anticipate having accumulated sufficient data to enable submission of a pre-market notification (510(k)) to the FDA for the Micro-Pumper (in conjunction with ShuntCheck). The result of this work will be an important change in the diagnostic algorithm currently used to manage symptomatic hydrocephalus patients. Given the need for a non-invasive method to accurately diagnose shunt failure, the potential savings over alternative methods and the potential for improved patient outcomes, the data from this study will support a product which is commercially viable and extremely important.

Public Health Relevance:
This proposal supports the development of a portable, non-invasive tool which will improve the diagnostic accuracy of CSF shunt patency testing such as radionuclide studies and ShuntCheck tests. This will improve clinical care for pediatric hydrocephalus patients with suspect shunt malfunction and could lead to an important change in the standard diagnostic pathway currently used to manage symptomatic hydrocephalus patients.

Thesaurus Terms:
0-11 Years Old; Abbreviations; Abdomen; Abdominal; Accident And Emergency Department; Accuracy Of Diagnosis; Acquired Brain Injury; Algorithms; Biomedical Engineering; Boston; Brain Injuries; Brain Ventricle; Cat Scan, X-Ray; Cat Scan; Csf Shunt; Ct X Ray; Ct Scan; Cephalalgia; Cephalgia; Cephalodynia; Cephalodynias; Cerebral Ventricles; Cerebrospinal Fluid; Cerebrospinal Fluid Shunts; Cerebrospinal Fluid Shunt (Csf) Procedure; Cerebrospinal Fluid Shunts Procedure; Cessation Of Life; Chicago; Child; Child Youth; Childhood; Children (0-21); City Of Boston; Clinic; Clinical; Clinical Evaluation; Clinical Testing; Collaborations; Computed Tomography; Computerized Axial Tomography (Computerized Tomography); Computerized Tomography, X-Ray; Cranial Pain; Data; Death; Detection; Development; Device Or Instrument Development; Devices; Diagnosis; Diagnostic; Diagnostic Specificity; Emi Scan; Emergency Department; Emergency Medicine; Emergency Room; Event; Exhibits; Exposure To; Flr; Failure (Biologic Function); Goals; Hand; Head Pain; Headache; Human; Human, Child; Human, General; Hydrocephalus; Hydrocephaly; Image; Infection; Investigation; Kinetic; Kinetics; Lead; Legal Patent; Liquid Substance; Mr Imaging; Mr Tomography; Mri; Magnetic Resonance Imaging; Magnetic Resonance Imaging Scan; Man (Taxonomy); Man, Modern; Marketing; Measures; Medical Device; Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance; Methods; Methods And Techniques; Methods, Other; Modeling; Nmr Imaging; Nmr Tomography; Nausea; Neurosurgeon; Notification; Nuclear Magnetic Resonance Imaging; Obstruction; Outcome; Patents; Pathology; Pathway Interactions; Patients; Pattern; Pb Element; Pediatric Hospitals; Performance; Phase; Philadelphia; Physicians; Physiologic Pulse; Pilot Projects; Programs (Pt); Programs [publication Type]; Pulse; Radiation; Radioactive Isotopes; Radioisotopes; Radionuclides; Reading; Risk; Sbir; Sbirs (R43/44); Savings; Science Of Neurosurgery; Series; Shunt; Shunt Device; Small Business Innovation Research; Small Business Innovation Research Grant; Specificity; Symptoms; Techniques; Testing; Time; Tomodensitometry; Tomography, Xray Computed; Universities; University Hospitals; Vibration; Vibration - Physical Agent; Work; X-Ray Computed Tomography; Zeugmatography; Base; Bioengineering; Bioengineering/Biomedical Engineering; Brain Damage; Brain Lesion (From Injury); Catscan; Children; Clinical Care; Clinical Research Site; Clinical Site; Clinical Test; Computed Axial Tomography; Computerized Axial Tomography; Computerized Tomography; Cost; Design; Designing; Device Development; Diagnostic Accuracy; Experience; Failure; Fluid; Fluid Flow; Heavy Metal Pb; Heavy Metal Lead; Imaging; Improved; Instrument Development; Liquid; Neurosurgery; Pathway; Pediatric; Pilot Study; Programs; Prototype; Public Health Relevance; Ray (Radiation); Research Clinical Testing; Shunts; Spinal Fluid; Surgeon, Neuro-; Tool; Validation Studies; Vibration; Youngster

Phase II

Contract Number: 2R44NS067772-02
Start Date: 3/1/10    Completed: 6/30/14
Phase II year
2011
(last award dollars: 2013)
Phase II Amount
$2,989,549

This Phase 2 SBIR will provide and clinically validate the first portable, non-invasive diagnostic test for differentiating intermittently flowing patent shunts from occluded or partially occluded shunts - ShuntCheck- Micro-Pumper. This device will result in improved clinical management of hydrocephalus by providing a rapid and non-invasive method for detecting CSF shunt obstruction in symptomatic patients, and, potentially for identifying oncoming occlusion before symptoms emerge. Hydrocephalus, a common condition in which CSF accumulates in the brain ventricles, is corrected by placing a VP shunt that drains excess CSF to the abdomen. Shunts frequently malfunction, usually by obstruction, but the symptoms of shunt failure are unspecific - headache, nausea. Diagnosis of shunt malfunction is expensive and presents risks (exposure to radiation from CT Scans, risk of infection from radionuclide testing) and no tools exist for predicting shunt malfunction. There are currently no non-invasive, non-radiologic technologies for assessing shunt function and malfunction. NeuroDx has developed a non-invasive device called ShuntCheck which uses thermal dilution to detect CSF flow in subcutaneous shunts. While clinical studies of ShuntCheck demonstrated the accuracy of flow/no-flow measurements, they showed that ""no-flow"" does not indicate an occluded shunt (since shunt flow can be intermittent) and ""flow"" does not indicate a patent shunt (since a partially occluded shunt can cause elevated ICP while allowing CSF flow). To address this problem, NeuroDx developed the Micro-Pumper, a small, handheld device which generates a temporary increase in CSF flow through patent but not occluded shunts. This ""micro-pumped"" flow can be detected by ShuntCheck as an indication of shunt flow capacity. In our Phase 1 studies, we developed operating parameters and a laboratory prototype Micro-Pumper that reliably generates increased CSF flow in a wide variety of patent, but not partially-obstructed, shunt valves. Repeated micro-pumping did not result in any adverse effects on shunt valve function. A pilot clinical study of the ShuntCheck-Micro-Pumper, currently underway at Children's Hospital Boston, indicates that the procedure is acceptable to pediatric patients and generates detectable flows in patent shunts. In Phase 2, we plan to develop a production ready version of the Micro-Pumper, optimize the ShuntCheck design for use with the Micro-Pumper and validate the accuracy of the combined procedure in human clinical studies. Pediatric shunt malfunction and management testing constitute approximately 310,000 shunt flow tests annually in the United States alone. NeuroDx's business model for this product involves the generation of revenue primarily from the ongoing sale of single-use, disposable sensors for these tests. The need for new diagnostic tools for managing hydrocephalus patients is highlighted by the NIH announcement ""Advanced Tools and Technologies for Cerebrospinal Fluid Shunts"" (PA-09-206), to which this proposal is responding. Our proposal directly responds to the request for Diagnostic tools for use in a hospital or outpatient setting that work in real-time to quantitatively determine shunt function.

Public Health Relevance:
This proposal addresses the need for diagnostic tools for use in a hospital or outpatient setting that work in real-time to quantitatively determine shunt function by providing the first portable, non-invasive diagnostic procedure for differentiating intermittently flowing patent shunts from occluded or partially occluded shunts. Obstruction of CSF shunts, a common complication in hydrocephalus, is currently diagnosed by radiation imaging techniques, such as CT Scan, or by invasive procedures, such as shunt tapping. This new tool will help neurosurgeons differentiate between intermittently flowing and obstructed shunts and potentially for identifying oncoming occlusion before symptoms emerge.

Thesaurus Terms:
Abdomen;Abdominal;Acquired Brain Injury;Address;Adverse Effects;Affect;American;Boston;Brain Dead;Brain Death;Brain Injuries;Brain Ventricle;Businesses;Cat Scan;Csf Shunt;Ct X Ray;Ct Scan;Cephalalgia;Cephalgia;Cephalodynia;Cerebral Ventricles;Cerebrospinal Fluid Shunts;Cerebrospinal Fluid Shunt (Csf) Procedure;Cerebrospinal Fluid Shunts Procedure;Childhood;Children's Hospital;Clinic;Clinical;Clinical Management;Clinical Research;Clinical Study;Collaborations;Coma Depasse;Complication;Computed Tomography;Computerized Axial Tomography (Computerized Tomography);Contracting Opportunities;Contracts;Cranial Pain;Data;Development;Device Or Instrument Development;Devices;Diagnosis;Diagnostic;Diagnostic Method;Diagnostic Procedure;Diagnostic Sensitivity;Diagnostic Specificity;Diagnostic Technique;Diagnostic Tests;Emi Scan;Exposure To;Fda Approved;Flr;Failure (Biologic Function);Generations;Goals;Head Pain;Headache;Health Care Costs;Health Costs;Healthcare Costs;Hospitals;Human;Hydrocephalus;Hydrocephaly;Imaging Procedures;Imaging Technics;Imaging Techniques;Infection;Loinc Axis 4 System;Laboratories;Legal Patent;Man (Taxonomy);Manufacturer;Manufacturer Name;Marketing;Measurement;Medical Device;Methods;Modeling;Modern Man;Nih;National Institutes Of Health;Nausea;Neurosurgeon;Notification;Obstruction;Out-Patients;Outcome;Outpatients;Patents;Patients;Pediatric Hospitals;Performance;Phase;Phase I Study;Pilot Projects;Procedures;Production;Pump;Radiation;Radiation, X-Rays, Gamma-Rays;Radioactive Isotopes;Radioisotopes;Radionuclides;Research;Risk;Roentgen Rays;Sbir;Sbirs (R43/44);Safety;Sales;Second Look;Second Look Surgery;Series;Shunt;Shunt Device;Small Business Innovation Research;Small Business Innovation Research Grant;Specificity;Surgical Revision;Symptoms;System;Technology;Testing;Time;Tomodensitometry;Treatment Side Effects;United States;United States National Institutes Of Health;Validation;Work;X-Radiation;X-Ray Cat Scan;X-Ray Computed Tomography;X-Ray Computerized Tomography;X-Rays;X-Rays Radiation;Xray Computed Tomography;Xrays;Brain Damage;Brain Lesion (From Injury);Catscan;Cerebral Death;Commercialization;Computed Axial Tomography;Computerized Axial Tomography;Computerized Tomography;Design;Designing;Developmental;Device Development;Experience;Failure;Head Ache;Improved;Innovate;Innovation;Innovative;Instrument Development;Neuro-Surgeon;Neurosurgery;New Diagnostics;Next Generation Diagnostics;Novel Diagnostics;Pediatric;Phase 1 Study;Pilot Study;Prototype;Rapid Method;Rapid Technique;Ray (Radiation);Response;Sensor;Shunts;Side Effect;Subcutaneous;Therapy Adverse Effect;Tool;Treatment Adverse Effect